Tags

Type your tag names separated by a space and hit enter

Inadequate compliance with periconceptional folic acid supplementation in South Australia.
Aust N Z J Obstet Gynaecol. 2006 Dec; 46(6):528-33.AN

Abstract

BACKGROUND

Despite recommendations for women to take folic acid supplements, there has been little reduction in the number of neural tube defect cases occurring each year.

AIMS

To assess the level of compliance of pregnant women to recommendations for folic acid supplementation in South Australia, and audit the labelled content in reported supplements used.

METHODS

A survey was conducted from May to September 2005 with 304 pregnant women recruited from antenatal clinics at the Lyell McEwin Health Service, the Women's and Children's Hospital and the Modbury Hospital in Adelaide.

RESULTS

Full compliance with supplementation recommendations for both timing and dose was achieved by 30% of women. Partial compliance was achieved by 43%, while 27% took no folic acid supplements.

CONCLUSIONS

There is currently poor compliance with folic acid supplementation around conception. Additional food fortification may better achieve an adequate daily level of folic acid.

Authors+Show Affiliations

Discipline of Obstetrics and Gynaecology, Women's and Children's Hospital, School of Paediatrics and Reproductive Health, The University of Adelaide, Adelaide, South Australia, Australia. melissa.conlin@student.adelaide.edu.auNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

17116059

Citation

Conlin, Melissa L., et al. "Inadequate Compliance With Periconceptional Folic Acid Supplementation in South Australia." The Australian & New Zealand Journal of Obstetrics & Gynaecology, vol. 46, no. 6, 2006, pp. 528-33.
Conlin ML, MacLennan AH, Broadbent JL. Inadequate compliance with periconceptional folic acid supplementation in South Australia. Aust N Z J Obstet Gynaecol. 2006;46(6):528-33.
Conlin, M. L., MacLennan, A. H., & Broadbent, J. L. (2006). Inadequate compliance with periconceptional folic acid supplementation in South Australia. The Australian & New Zealand Journal of Obstetrics & Gynaecology, 46(6), 528-33.
Conlin ML, MacLennan AH, Broadbent JL. Inadequate Compliance With Periconceptional Folic Acid Supplementation in South Australia. Aust N Z J Obstet Gynaecol. 2006;46(6):528-33. PubMed PMID: 17116059.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Inadequate compliance with periconceptional folic acid supplementation in South Australia. AU - Conlin,Melissa L, AU - MacLennan,Alastair H, AU - Broadbent,Jessica L, PY - 2006/11/23/pubmed PY - 2007/2/14/medline PY - 2006/11/23/entrez SP - 528 EP - 33 JF - The Australian & New Zealand journal of obstetrics & gynaecology JO - Aust N Z J Obstet Gynaecol VL - 46 IS - 6 N2 - BACKGROUND: Despite recommendations for women to take folic acid supplements, there has been little reduction in the number of neural tube defect cases occurring each year. AIMS: To assess the level of compliance of pregnant women to recommendations for folic acid supplementation in South Australia, and audit the labelled content in reported supplements used. METHODS: A survey was conducted from May to September 2005 with 304 pregnant women recruited from antenatal clinics at the Lyell McEwin Health Service, the Women's and Children's Hospital and the Modbury Hospital in Adelaide. RESULTS: Full compliance with supplementation recommendations for both timing and dose was achieved by 30% of women. Partial compliance was achieved by 43%, while 27% took no folic acid supplements. CONCLUSIONS: There is currently poor compliance with folic acid supplementation around conception. Additional food fortification may better achieve an adequate daily level of folic acid. SN - 0004-8666 UR - https://www.unboundmedicine.com/medline/citation/17116059/Inadequate_compliance_with_periconceptional_folic_acid_supplementation_in_South_Australia_ L2 - https://doi.org/10.1111/j.1479-828X.2006.00654.x DB - PRIME DP - Unbound Medicine ER -